Skip to main content
Figure 1 | Allergy, Asthma & Clinical Immunology

Figure 1

From: Effect of allergen-specific immunotherapy with purified Alt a1 on AMP responsiveness, exhaled nitric oxide and exhaled breath condensate pH: a randomized double blind study

Figure 1

Individual values for the adenosine 5'-monophosphate (AMP) and methacholine bronchial responsiveness index (BRI) in the specific immunotherapy and placebo groups at baseline and after 6 and 12 months of treatment. Horizontal lines are geometric means. Changes in AMP BRI values were not significantly different between the SIT and placebo groups (P = 0.35 and P = 0.50 for changes at 6 and 12 months of treatment, respectively). Furthermore, changes in methacholine BRI values were not significantly different between the SIT and placebo groups (P = 0.92 and P = 0.61 for changes at 6 and 12 months of treatment, respectively).

Back to article page